AnaptysBio Inc’s recently made public that its Director HOLLINGS C RENTON acquired Company’s shares for reported $0.2 million on Aug 08 ’25. In the deal valued at $19.62 per share,10,231 shares were bought.
Then, RENTON HOLLINGS sold 20,925 shares, generating $493,191 in total proceeds. Upon selling the shares at $23.57, the Director now owns 4,965 shares.
Before that, HOLLINGS C RENTON bought 20,925 shares. AnaptysBio Inc shares valued at $493,190 were divested by the Director at a price of $23.57 per share.
H.C. Wainwright upgraded its AnaptysBio Inc [ANAB] rating to a Buy from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in early February with a ‘”an Outperform”‘ rating. H.C. Wainwright also remained covering ANAB and has decreased its forecast on December 11, 2024 with a “Neutral” recommendation from previously “Buy” rating. BTIG Research revised its rating on December 02, 2024. It rated ANAB as “a Neutral” which previously was an “a Buy”.
Price Performance Review of ANAB
On Monday, AnaptysBio Inc [NASDAQ:ANAB] saw its stock fall -4.90% to $20.0. Over the last five days, the stock has lost -17.46%. AnaptysBio Inc shares have fallen nearly -36.59% since the year began. Nevertheless, the stocks have risen 51.06% over the past one year. While a 52-week high of $41.31 was reached on 07/24/25, a 52-week low of $12.21 was recorded on 02/11/25.
Levels Of Support And Resistance For ANAB Stock
The 24-hour chart illustrates a support level at 19.53, which if violated will result in even more drops to 19.05. On the upside, there is a resistance level at 20.82. A further resistance level may holdings at 21.63.
How much short interest is there in AnaptysBio Inc?
A steep rise in short interest was recorded in AnaptysBio Inc stocks on 2025-07-15, growing by 0.23 million shares to a total of 9.38 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 9.15 million shares. There was a rise of 2.42%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 22, 2024 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $55 price target.
